| 1 |
Pop TL, Sîrbe C, Benţa G, Mititelu A, Grama A. The Role of Vitamin D and Vitamin D Binding Protein in Chronic Liver Diseases. IJMS 2022;23:10705. [DOI: 10.3390/ijms231810705] [Reference Citation Analysis]
|
| 2 |
Resino S, Jiménez-sousa MÁ, Blanco J, Pacheco YM, del Romero J, Peraire J, Virseda-berdices A, Muñoz-gómez MJ, Galera-peñaranda C, García-fraile LJ, Benito JM, Rallón N. DBP rs7041 and DHCR7 rs3829251 are Linked to CD4+ Recovery in HIV Patients on Antiretroviral Therapy. Front Pharmacol 2022;12:773848. [DOI: 10.3389/fphar.2021.773848] [Reference Citation Analysis]
|
| 3 |
Paria K, Paul D, Chowdhury T, Pyne S, Chakraborty R, Mandal SM. Synergy of melanin and vitamin-D may play a fundamental role in preventing SARS-CoV-2 infections and halt COVID-19 by inactivating furin protease. Transl Med Commun 2020;5:21. [PMID: 33169107 DOI: 10.1186/s41231-020-00073-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 4 |
Udomsinprasert W, Jittikoon J, Sukkho S, Pojarassangkul N, Sangroongruangsri S, Chaikledkaew U. Decreased circulating vitamin D reflects adverse outcomes of hepatitis C virus infection: A systematic review and meta-analysis. J Infect 2020;81:585-99. [PMID: 32553842 DOI: 10.1016/j.jinf.2020.06.025] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 5 |
Lee C. Controversial Effects of Vitamin D and Related Genes on Viral Infections, Pathogenesis, and Treatment Outcomes. Nutrients 2020;12:E962. [PMID: 32235600 DOI: 10.3390/nu12040962] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 6 |
Barooah P, Saikia S, Bharadwaj R, Sarmah P, Bhattacharyya M, Goswami B, Medhi S. Role of VDR, GC, and CYP2R1 Polymorphisms in the Development of Hepatocellular Carcinoma in Hepatitis C Virus-Infected Patients. Genet Test Mol Biomarkers 2019;23:325-31. [PMID: 30942619 DOI: 10.1089/gtmb.2018.0170] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 7 |
Xie CN, Yue M, Huang P, Tian T, Fan HZ, Wu MP, Yu RB, Yi HG, Xia XS, Feng Y, Zhang Y, Wang J. Vitamin D binding protein polymorphisms influence susceptibility to hepatitis C virus infection in a high-risk Chinese population. Gene 2018;679:405-11. [PMID: 30218750 DOI: 10.1016/j.gene.2018.09.021] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 8 |
Frias M, Rivero-Juárez A, López-López P, Rivero A. Pharmacogenetics and the treatment of HIV-/HCV-coinfected patients. Pharmacogenomics 2018;19:979-95. [PMID: 29992850 DOI: 10.2217/pgs-2018-0046] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 9 |
Chausmer AB. A critical review of the assessment of Vitamin D status. EMIJ 2018;6. [DOI: 10.15406/emij.2018.06.00185] [Reference Citation Analysis]
|
| 10 |
Abhimanyu, Coussens AK. The role of UV radiation and vitamin D in the seasonality and outcomes of infectious disease. Photochem Photobiol Sci 2017;16:314-38. [PMID: 28078341 DOI: 10.1039/c6pp00355a] [Cited by in Crossref: 63] [Cited by in F6Publishing: 65] [Article Influence: 12.6] [Reference Citation Analysis]
|
| 11 |
Keane JT, Elangovan H, Stokes RA, Gunton JE. Vitamin D and the Liver-Correlation or Cause? Nutrients 2018;10:E496. [PMID: 29659559 DOI: 10.3390/nu10040496] [Cited by in Crossref: 54] [Cited by in F6Publishing: 58] [Article Influence: 10.8] [Reference Citation Analysis]
|
| 12 |
Scalioni LP, Santos BRD, Spritzer PM, Villela-Nogueira CA, Laura Lewis-Ximenez L, Pollo-Flores P, Bordalo Cathalá Esberard E, Brandão-Mello CE, Lampe E, Villar LM. Impact of vitamin D receptor and binding protein gene polymorphisms in clinical and laboratory data of HCV patients: Cross sectional study. Medicine (Baltimore) 2018;97:e9881. [PMID: 29465575 DOI: 10.1097/MD.0000000000009881] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 13 |
Westhaus S, Deest M, Nguyen ATX, Stanke F, Heckl D, Costa R, Schambach A, Manns MP, Berg T, Vondran FWR, Sarrazin C, Ciesek S, von Hahn T. Scavenger receptor class B member 1 (SCARB1) variants modulate hepatitis C virus replication cycle and viral load. J Hepatol 2017;67:237-45. [PMID: 28363797 DOI: 10.1016/j.jhep.2017.03.020] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 14 |
Vasudevan S, Kavimandan A, Kalra N, Nayak B, Thakur B, Das P, Gupta SD, Panda SK, Acharya SK; Shalimar. Demographic profile, host, disease & viral predictive factors of response in patients with chronic hepatitis C virus infection at a tertiary care hospital in north India. Indian J Med Res 2016;143:331-40. [PMID: 27241647 DOI: 10.4103/0971-5916.182624] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 15 |
Thanapirom K, Suksawatamnuay S, Sukeepaisarnjaroen W, Tangkijvanich P, Treeprasertsuk S, Thaimai P, Wasitthankasem R, Poovorawan Y, Komolmit P. Vitamin D-related gene polymorphism predict treatment response to pegylated interferon-based therapy in Thai chronic hepatitis C patients. BMC Gastroenterol 2017;17:54. [PMID: 28415985 DOI: 10.1186/s12876-017-0613-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 16 |
Komolmit P, Charoensuk K, Thanapirom K, Suksawatamnuay S, Thaimai P, Chirathaworn C, Poovorawan Y. Correction of vitamin D deficiency facilitated suppression of IP-10 and DPP IV levels in patients with chronic hepatitis C: A randomised double-blinded, placebo-control trial. PLoS One 2017;12:e0174608. [PMID: 28376103 DOI: 10.1371/journal.pone.0174608] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 17 |
Thanapirom K, Suksawatamnuay S, Sukeepaisarnjareon W, Tanwandee T, Charatcharoenwitthaya P, Thongsawat S, Leerapun A, Piratvisuth T, Boonsirichan R, Bunchorntavakul C, Pattanasirigool C, Pornthisarn B, Tantipanichtheerakul S, Sripariwuth E, Jeamsripong W, Sanpajit T, Poovorawan Y, Komolmit P. Genetic variation in the vitamin D pathway CYP2R1 gene predicts sustained HBeAg seroconversion in chronic hepatitis B patients treated with pegylated interferon: A multicenter study. PLoS One 2017;12:e0173263. [PMID: 28296915 DOI: 10.1371/journal.pone.0173263] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 18 |
Loftfield E, O'Brien TR, Pfeiffer RM, Howell CD, Horst R, Prokunina-Olsson L, Weinstein SJ, Albanes D, Morgan TR, Freedman ND. Vitamin D Status and Virologic Response to HCV Therapy in the HALT-C and VIRAHEP-C Trials. PLoS One 2016;11:e0166036. [PMID: 27832143 DOI: 10.1371/journal.pone.0166036] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 19 |
Belle A, Gizard E, Conroy G, Lopez A, Bouvier-Alias M, Rouanet S, Peyrin-Biroulet L, Pawlotsky JM, Bronowicki JP. 25-OH vitamin D level has no impact on the efficacy of antiviral therapy in naïve genotype 1 HCV-infected patients. United European Gastroenterol J 2017;5:69-75. [PMID: 28405324 DOI: 10.1177/2050640616640157] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 20 |
Wu M, Yue M, Huang P, Zhang Y, Xie C, Yu R, Li J, Wang J. Vitamin D level and vitamin D receptor genetic variations contribute to HCV infection susceptibility and chronicity in a Chinese population. Infect Genet Evol 2016;41:146-52. [PMID: 27063396 DOI: 10.1016/j.meegid.2016.03.032] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 21 |
Chan HL, Elkhashab M, Trinh H, Tak WY, Ma X, Chuang WL, Kim YJ, Martins EB, Lin L, Dinh P, Charuworn P, Foster GR, Marcellin P. Association of baseline vitamin D levels with clinical parameters and treatment outcomes in chronic hepatitis B. J Hepatol 2015;63:1086-92. [PMID: 26143444 DOI: 10.1016/j.jhep.2015.06.025] [Cited by in Crossref: 39] [Cited by in F6Publishing: 44] [Article Influence: 4.9] [Reference Citation Analysis]
|
| 22 |
Kitson MT, Sarrazin C, Toniutto P, Roberts SK. Relationship between vitamin D status and response to hepatitis C virus therapy. Hepatology 2015;62:1642-3. [PMID: 25808060 DOI: 10.1002/hep.27797] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 23 |
Pineda-Tenor D, García-Álvarez M, Jiménez-Sousa MA, Fernández-Rodríguez A, Resino S. Reply: To PMID 24975775. Hepatology 2015;62:1643. [PMID: 25807876 DOI: 10.1002/hep.27796] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 24 |
Coppola N, Pisaturo M, Sagnelli C, Onorato L, Sagnelli E. Role of genetic polymorphisms in hepatitis C virus chronic infection. World J Clin Cases 2015; 3(9): 807-822 [PMID: 26380828 DOI: 10.12998/wjcc.v3.i9.807] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 25 |
Atsukawa M, Tsubota A, Shimada N, Yoshizawa K, Abe H, Asano T, Ohkubo Y, Araki M, Ikegami T, Kondo C. Influencing factors on serum 25-hydroxyvitamin D3 levels in Japanese chronic hepatitis C patients. BMC Infect Dis. 2015;15:344. [PMID: 26286329 DOI: 10.1186/s12879-015-1020-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 26 |
Arai T, Atsukawa M, Tsubota A, Kondo C, Shimada N, Abe H, Itokawa N, Nakagawa A, Okubo T, Aizawa Y, Iwakiri K. Vitamin D-related gene polymorphisms do not influence the outcome and serum vitamin D level in pegylated interferon/ribavirin therapy combined with protease inhibitor for patients with genotype 1b chronic hepatitis C: Vitamin D-Related Gene Polymorphisms for Hepatitis C. J Med Virol 2015;87:1904-12. [DOI: 10.1002/jmv.24244] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 27 |
Watkins RR, Lemonovich TL, Salata RA. An update on the association of vitamin D deficiency with common infectious diseases. Can J Physiol Pharmacol 2015;93:363-8. [PMID: 25741906 DOI: 10.1139/cjpp-2014-0352] [Cited by in Crossref: 71] [Cited by in F6Publishing: 74] [Article Influence: 8.9] [Reference Citation Analysis]
|
| 28 |
Anema A, Mehra D, Weiser S, Grede N, Vogenthaler N, Kerr T. Drivers and Consequences of Food Insecurity Among Illicit Drug Users. Health of HIV Infected People 2015. [DOI: 10.1016/b978-0-12-800769-3.00020-2] [Cited by in Crossref: 4] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 29 |
Atsukawa M, Tsubota A, Shimada N, Kondo C, Itokawa N, Nakagawa A, Hashimoto S, Fukuda T, Matsushita Y, Narahara Y, Iwakiri K, Nakatsuka K, Kawamoto C, Sakamoto C. Serum 25-hydroxyvitamin D3 levels affect treatment outcome in pegylated interferon/ribavirin combination therapy for compensated cirrhotic patients with hepatitis C virus genotype 1b and high viral load. Hepatol Res 2014;44:1277-85. [PMID: 24417888 DOI: 10.1111/hepr.12298] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 30 |
Chen EQ, Shi Y, Tang H. New insight of vitamin D in chronic liver diseases. Hepatobiliary Pancreat Dis Int 2014;13:580-5. [PMID: 25475859 DOI: 10.1016/s1499-3872(14)60295-2] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 31 |
García-Álvarez M, Pineda-Tenor D, Jiménez-Sousa MA, Fernández-Rodríguez A, Guzmán-Fulgencio M, Resino S. Relationship of vitamin D status with advanced liver fibrosis and response to hepatitis C virus therapy: a meta-analysis. Hepatology 2014;60:1541-50. [PMID: 24975775 DOI: 10.1002/hep.27281] [Cited by in Crossref: 59] [Cited by in F6Publishing: 63] [Article Influence: 6.6] [Reference Citation Analysis]
|
| 32 |
Atsukawa M, Tsubota A, Shimada N, Abe H, Kondo C, Itokawa N, Nakagawa A, Iwakiri K, Kawamoto C, Aizawa Y, Sakamoto C. Serum 25(OH)D3 levels affect treatment outcomes for telaprevir/peg-interferon/ribavirin combination therapy in genotype 1b chronic hepatitis C. Dig Liver Dis 2014;46:738-43. [PMID: 24880716 DOI: 10.1016/j.dld.2014.05.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 33 |
Anty R, Tonohouan M, Ferrari-Panaia P, Piche T, Pariente A, Anstee QM, Gual P, Tran A. Low Levels of 25-Hydroxy Vitamin D are Independently Associated with the Risk of Bacterial Infection in Cirrhotic Patients. Clin Transl Gastroenterol. 2014;5:e56. [PMID: 24871371 DOI: 10.1038/ctg.2014.6] [Cited by in Crossref: 33] [Cited by in F6Publishing: 37] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 34 |
Navas-Nazario A, Li FY, Shabanova V, Weiss P, Cole DE, Carpenter TO, Bazzy-Asaad A. Effect of vitamin D-binding protein genotype on the development of asthma in children. Ann Allergy Asthma Immunol 2014;112:519-24. [PMID: 24745702 DOI: 10.1016/j.anai.2014.03.017] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 35 |
Grammatikos G, Lange C, Susser S, Schwendy S, Dikopoulos N, Buggisch P, Encke J, Teuber G, Goeser T, Thimme R. Vitamin D levels vary during antiviral treatment but are unable to predict treatment outcome in HCV genotype 1 infected patients. PLoS One. 2014;9:e87974. [PMID: 24516573 DOI: 10.1371/journal.pone.0087974] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 36 |
Amanzada A, Goralczyk AD, Moriconi F, van Thiel DH, Ramadori G, Mihm S. Vitamin D status and serum ferritin concentration in chronic hepatitis C virus type 1 infection. J Med Virol. 2013;85:1534-1541. [PMID: 23852677 DOI: 10.1002/jmv.23632] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 37 |
Branch AD, Barin B, Rahman A, Stock P, Schiano TD. Vitamin D status of human immunodeficiency virus-positive patients with advanced liver disease enrolled in the solid organ transplantation in HIV: multi-site study. Liver Transpl 2014;20:156-64. [PMID: 24338934 DOI: 10.1002/lt.23784] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 38 |
Speeckaert MM, Speeckaert R, van Geel N, Delanghe JR. Vitamin D binding protein: a multifunctional protein of clinical importance. Adv Clin Chem 2014;63:1-57. [PMID: 24783350 DOI: 10.1016/b978-0-12-800094-6.00001-7] [Cited by in Crossref: 81] [Cited by in F6Publishing: 85] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 39 |
Falleti E, Cmet S, Fabris C, Fattovich G, Cussigh A, Bitetto D, Ceriani E, Lenisa I, Dissegna D, Ieluzzi D. Genetic polymorphisms of vitamin D pathway predict antiviral treatment outcome in slow responder naïve patients with chronic hepatitis C. PLoS One. 2013;8:e80764. [PMID: 24244713 DOI: 10.1371/journal.pone.0080764] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 40 |
Guzmán-Fulgencio M, García-Álvarez M, Berenguer J, Jiménez-Sousa MÁ, Cosín J, Pineda-Tenor D, Carrero A, Aldámiz T, Alvarez E, López JC, Resino S. Vitamin D deficiency is associated with severity of liver disease in HIV/HCV coinfected patients. J Infect. 2014;68:176-184. [PMID: 24184809 DOI: 10.1016/j.jinf.2013.10.011] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 41 |
Smyk DS, Orfanidou T, Invernizzi P, Bogdanos DP, Lenzi M. Vitamin D in autoimmune liver disease. Clin Res Hepatol Gastroenterol 2013;37:535-45. [PMID: 23845396 DOI: 10.1016/j.clinre.2013.05.016] [Cited by in Crossref: 37] [Cited by in F6Publishing: 41] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 42 |
Falleti E, Fabris C, Toniutto P. Reply: To PMID 22610885. Hepatology 2013;58:1864-5. [PMID: 23553733 DOI: 10.1002/hep.26435] [Reference Citation Analysis]
|
| 43 |
Weintraub SJ, Fleckenstein JF, Marion TN, Madey MA. Vitamin D-binding protein gene polymorphisms may contribute to the racial disparity in genotype 1 chronic hepatitis C treatment outcome. Hepatology 2013;58:1864. [PMID: 23553666 DOI: 10.1002/hep.26432] [Reference Citation Analysis]
|
| 44 |
Lee T, Tillmann HL, Patel K. Individualized Therapy for Hepatitis C Infection: Focus on the Interleukin-28B Polymorphism in Directing Therapy. Mol Diagn Ther 2014;18:25-38. [DOI: 10.1007/s40291-013-0053-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 45 |
Han YP, Kong M, Zheng S, Ren Y, Zhu L, Shi H, Duan Z. Vitamin D in liver diseases: from mechanisms to clinical trials. J Gastroenterol Hepatol 2013;28 Suppl 1:49-55. [PMID: 23855296 DOI: 10.1111/jgh.12016] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 3.9] [Reference Citation Analysis]
|
| 46 |
Branch AD, Kang M, Hollabaugh K, Wyatt CM, Chung RT, Glesby MJ. In HIV/hepatitis C virus co-infected patients, higher 25-hydroxyvitamin D concentrations were not related to hepatitis C virus treatment responses but were associated with ritonavir use. Am J Clin Nutr 2013;98:423-9. [PMID: 23739141 DOI: 10.3945/ajcn.112.048785] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 47 |
Kitson MT, Button P, Roberts SK; CHARIOT Publication Steering Committee. Reply to: "Vitamin D status does not predict sustained virologic response or fibrosis stage in chronic hepatitis C genotype 1 infection". J Hepatol 2013;59:194-5. [PMID: 23500151 DOI: 10.1016/j.jhep.2013.03.001] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
|
| 48 |
Weintraub SJ. Vitamin D status does not predict sustained virologic response or fibrosis stage in chronic hepatitis C genotype 1 infection. J Hepatol 2013;59:193-4. [PMID: 23500149 DOI: 10.1016/j.jhep.2013.02.027] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 49 |
White DL, Tavakoli-Tabasi S, Kanwal F, Ramsey DJ, Hashmi A, Kuzniarek J, Patel P, Francis J, El-Serag HB. The association between serological and dietary vitamin D levels and hepatitis C-related liver disease risk differs in African American and white males. Aliment Pharmacol Ther 2013;38:28-37. [PMID: 23710689 DOI: 10.1111/apt.12341] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 50 |
Manns MP, von Hahn T. Novel therapies for hepatitis C — one pill fits all? Nat Rev Drug Discov 2013;12:595-610. [DOI: 10.1038/nrd4050] [Cited by in Crossref: 155] [Cited by in F6Publishing: 159] [Article Influence: 15.5] [Reference Citation Analysis]
|
| 51 |
Rau M, Baur K, Geier A. Host genetic variants in the pathogenesis of hepatitis C. Viruses 2012;4:3281-302. [PMID: 23342360 DOI: 10.3390/v4123281] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 52 |
Rahman AH, Branch AD. Vitamin D for your patients with chronic hepatitis C? J Hepatol 2013;58:184-9. [PMID: 22871501 DOI: 10.1016/j.jhep.2012.07.026] [Cited by in Crossref: 33] [Cited by in F6Publishing: 38] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 53 |
Booth DR, Ahlenstiel G, George J. Pharmacogenomics of hepatitis C infections: personalizing therapy. Genome Med 2012;4:99. [PMID: 23268841 DOI: 10.1186/gm400] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 54 |
Puri P. Will vitamin d supplementation have a role in the treatment of patients with chronic hepatitis C? J Clin Exp Hepatol 2012;2:396-8. [PMID: 25755461 DOI: 10.1016/j.jceh.2012.10.008] [Reference Citation Analysis]
|
| 55 |
Weintraub SJ, Fleckenstein JF, Marion TN, Madey MA, Mahmoudi TM, Schechtman KB. Vitamin D and the racial difference in the genotype 1 chronic hepatitis C treatment response. Am J Clin Nutr 2012;96:1025-31. [PMID: 23015322 DOI: 10.3945/ajcn.112.039974] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
|
